[1] Wu K, Lund M, Bang K, et al. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma. Cancer, 1999, 86:1056-1063. [2] Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science, 1997, 277:955-959. [3] Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science,1994, 266:2011-2015. [4] Collins K, Kobayashi R, Greider CW. Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell, 1995, 81:677-686. [5] Counter CM, Meyerson M, Eaton EN, et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene, 1998, 16:1217-1222. [6] Nakayama T, Tahara H, Tahara E, et al. Telomerase activation by hTERT in human fibroblasts and hepatocellular carcinomas. Nat Genet, 1998, 18:65-68. [7] Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science, 1998,279:349-352. [8] Vonderheide RH, Hahn WC, Schultze JL, et al. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity, 1999, 10:673-679. [9] 王孝养,张珍祥,徐永健,等.端粒酶逆转录酶基因反义寡核苷酸抑制肺癌细胞端粒酶活性和诱导细胞凋亡.中华内科杂志,2002,41:175-178. |